Conotoxin Pharmacology and Neuromuscular Mechanisms

Conotoxins are a diverse family of disulfide-rich peptides produced by marine cone snails (genus Conus) that exert highly selective actions on ion channels, ligand-gated receptors and transporters within the nervous system. Their precision targeting of voltage-gated sodium, potassium and calcium channels, as well as nicotinic acetylcholine receptors, underpins both their ecological role in prey capture and their therapeutic potential as analgesics and neuromodulators. At the neuromuscular junction, conotoxins can inhibit synaptic transmission by blocking presynaptic calcium influx or by antagonising postsynaptic acetylcholine receptors, thereby inducing paralysis in prey and offering templates for pain management and muscle-disorder treatments. Advances in transcriptomics, proteomics and structural biology have unveiled extensive gene superfamily diversity and post-translational modifications that generate thousands of distinct conopeptides. Understanding the molecular interactions of conotoxins with neuromuscular targets has deepened insights into synaptic physiology, informed the design of more stable peptide analogues, and spotlighted conotoxin-derived compounds as valuable pharmacological probes and drug candidates.

Research from Nature Portfolio

Recent studies have elucidated how conotoxin repertoires shift during development in Conus magus, revealing coordinated changes in feeding behaviour, radular morphology and venom composition that reflect prey-type transitions and highlight juvenile-stage peptides as a source of novel pharmacological tools. In parallel, investigations into modulators of nicotinic acetylcholine receptors have uncovered phosphocholine as a silent agonist at α9-containing receptors, selectively invoking metabotropic pathways without triggering ion flux, thereby broadening the conceptual framework for ligand–receptor interactions at neuromuscular and immunomodulatory sites.

Conotoxin Pharmacology and Neuromuscular Mechanisms publication trend

The graph below shows the total number of articles in conotoxin pharmacology and neuromuscular mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

Conotoxin: A peptide toxin from cone snail venom composed of disulfide-bonded cystine frameworks that target ion channels and receptors.

Neuromuscular junction: The synapse between a motor neuron and muscle fibre where neurotransmitters induce muscle contraction.

Voltage-gated ion channel: A membrane protein that opens or closes in response to changes in membrane potential, crucial for action potential propagation.

Backbone cyclisation: A peptide modification that links its N- and C-termini to improve structural stability and resistance to proteolysis.

Silent agonist: A ligand that binds a receptor and induces conformational changes without triggering the canonical ion-conducting response, favouring non-conductive signalling.

References

1. Coordinated adaptations define the ontogenetic shift from worm- to fish-hunting in a venomous cone snail. Nature Communications (2023).
2. Phosphocholine – an agonist of metabotropic but not of ionotropic functions of α9-containing nicotinic acetylcholine receptors. Scientific Reports (2016).
3. A Chemoenzymatic Approach To Produce a Cyclic Analogue of the Analgesic Drug MVIIA (Ziconotide). Angewandte Chemie International Edition (2023).
4. δ‐Conotoxin Structure Prediction and Analysis through Large‐Scale Comparative and Deep Learning Modeling Approaches. Advanced Science (2024).
5. A previously unrecognized superfamily of macro-conotoxins includes an inhibitor of the sensory neuron calcium channel Cav2.3.. PLOS Biology (2023).